Genome Editing Biotech EdiGene Raises $10 Million in Series pre-B Plus Financing and Strengthens Management Team
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 4, 2019--EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into cr…
